• About
  • Advertise
  • Privacy & Policy
  • Contact
Thursday, December 25, 2025
Bislad News
  • Login
  • Home
  • Politics
  • Insurance
  • Pension
  • Paper Presentation
  • Opinion
  • Back In The Days
  • News
  • Business
  • Features
  • Photo Gallery
  • Sports
No Result
View All Result
  • Home
  • Politics
  • Insurance
  • Pension
  • Paper Presentation
  • Opinion
  • Back In The Days
  • News
  • Business
  • Features
  • Photo Gallery
  • Sports
No Result
View All Result
Bislad News
No Result
View All Result

Katalin Kariko, Drew Weissman Wins Nobel Prize For Medicine After Creating Game-changing mRNA Jabs During Covid 

by Oluwadamilola Olaleye
October 2, 2023
in Features, News
Katalin Kariko, Drew Weissman Wins Nobel Prize For Medicine After Creating Game-changing mRNA Jabs During Covid 
Share this:

Two scientists whose pioneering work helped create mRNA Covid vaccines were today awarded the Nobel Prize for Medicine in person Katalin Karikó and Drew Weissman with the duo credited with helping to change the course of the pandemic.

Before mRNA jabs were rolled out to millions of people worldwide to protect them against Covid, such technology was considered experimental. Researchers are now exploring if it could help beat cancer and other diseases.

The US scientist and Hungarian peer first met in the 1990s while working at the University of Pennsylvania after a chance meeting while photocopying research papers as they realized their shared interest before embarking on their decades-long mission to help make better jabs.

Read Also:

NIMC Introduces Pre-Enrolment Portal To Enhance NIN Registration Experience

NLNG’s MD, Philip Mshelbila, Bows Out After Tenure; Falade Set To Take Over

Their work saw them jointly develop so-called nucleoside base modifications, which stop the immune system from launching an inflammatory attack against laboratory-made mRNA — once seen as a major hurdle against any therapeutic use of the tech.

The duos ‘groundbreaking findings’ have ‘fundamentally changed our understanding of how mRNA interacts with our immune system’, the Nobel Assembly said.

They contributed to the ‘unprecedented rate of vaccine development during one of the greatest threats to human health in modern times’, they added.

While the prize-winning science dates back to 2005, the first vaccines to use the mRNA technology were those made by Pfizer/BioNTech and Moderna against Covid.

mRNA is the genetic blueprint that instructs cells to make proteins in the body.

Tags: Drew WeissmanKatalin KarikóNobel Prize for Medicine
Previous Post

Scottish Premier League: Rangers FC Sack Michael Beale Following Woeful Season Start

Next Post

FIFA – Football For Schools Returns To Qatar With Seminar Designed For Women

Oluwadamilola Olaleye

Oluwadamilola Olaleye

Related Posts

NIMC Introduces Pre-Enrolment Portal To Enhance NIN Registration Experience
News

NIMC Introduces Pre-Enrolment Portal To Enhance NIN Registration Experience

December 19, 2025
NLNG’s MD, Philip Mshelbila, Bows Out After Tenure; Falade Set To Take Over
News

NLNG’s MD, Philip Mshelbila, Bows Out After Tenure; Falade Set To Take Over

December 15, 2025
Promotion Galore At NIMC As Year 2025 Ends.
News

Promotion Galore At NIMC As Year 2025 Ends.

December 15, 2025
NLNG Outlines Path To Sustainable LNG At World LNG Summit
News

NLNG Outlines Path To Sustainable LNG At World LNG Summit

December 8, 2025
Again, NNPC Ltd Cautions Against Panic Buying
News

2024 Financial Year : NPC Limited Declares ₦5.4 Trillion Profit After Tax

November 24, 2025
NLNG Hosts NCDMB, Others ln Stakeholders’ Retreat, Commits To Deepening Collaboration
News

NLNG Hosts NCDMB, Others ln Stakeholders’ Retreat, Commits To Deepening Collaboration

November 23, 2025
Next Post
FIFA – Football For Schools Returns To Qatar With Seminar Designed For Women

FIFA - Football For Schools Returns To Qatar With Seminar Designed For Women

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent News

Shareholders Approve Guinea Insurance’s Capital Raise Plan At Extraordinary General Meeting

Shareholders Approve Guinea Insurance’s Capital Raise Plan At Extraordinary General Meeting

3 days ago
NAICOM Hosts Takaful Advisory Council (TAC), Reaffirms Commitment To Takaful Insurance Development

NAICOM Hosts Takaful Advisory Council (TAC), Reaffirms Commitment To Takaful Insurance Development

6 days ago
NIMC Introduces Pre-Enrolment Portal To Enhance NIN Registration Experience

NIMC Introduces Pre-Enrolment Portal To Enhance NIN Registration Experience

6 days ago
PenCom needs strong board to sustain pension sector growth – Takor

MUST READ : Speech By DG PenCom, Oloworaran On 365-Day Score Card ln Office

7 days ago

Bisladnews.com is an online publication of Bislad Communication Network Company. It is a news platform dedicated to providing top news.

Follow Us

Browse by Category

  • Back in the days
  • Business
  • Features
  • Insurance
  • Interview
  • News
  • Opinion
  • Paper Presentation
  • Pension
  • Photo Gallery
  • Politics
  • Sports
  • Uncategorized

Recent News

Shareholders Approve Guinea Insurance’s Capital Raise Plan At Extraordinary General Meeting

Shareholders Approve Guinea Insurance’s Capital Raise Plan At Extraordinary General Meeting

December 22, 2025
NAICOM Hosts Takaful Advisory Council (TAC), Reaffirms Commitment To Takaful Insurance Development

NAICOM Hosts Takaful Advisory Council (TAC), Reaffirms Commitment To Takaful Insurance Development

December 19, 2025
  • Home
  • Politics
  • Insurance
  • Pension
  • Paper Presentation
  • Opinion
  • Back In The Days
  • News
  • Business
  • Features
  • Photo Gallery
  • Sports

©2024 - Bislad News

No Result
View All Result
  • Home
  • Politics
  • Insurance
  • Pension
  • Paper Presentation
  • Opinion
  • Back In The Days
  • News
  • Business
  • Features
  • Photo Gallery
  • Sports

©2024 - Bislad News

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In